Misonix Announces $97M Acquisition Of Solys Medical

Medical device maker Misonix, Inc. MSON announced Thursday that it entered a definitive agreement to acquire privately held Solsys Medical, LLC in an all-stock transaction valued at about $97 million. 

What Happened

Per the deal, Misonix said it will issue approximately 5.7 million new shares to Solys unitholders. 

After the deal closes, Misonix shareholders will own 64 percent of the combined entity and Solys unitholders will own 36 percent, according to the press release.

Misonix said it will assume Solys' outstanding secured debt of roughly $20 million. 

Why It's Important

Solys markets an advanced wound care product, TheraSkin, which is a cellular- and tissue-based product for regenerative wound healing that's designed to treat difficult-to-heal chronic wounds. 

The acquisition of Solys adds to Misonix's addressable market with wound care solutions that are complementary to Misonix's existing products, according to the announcement. 

Solys is expected to achieve sales about $32 million in calendar 2019, and the pro forma company is expected to generate more than $80 million in sales. The combined company expects top-line annual revenue growth of more than 20 percent in the coming years. 

What's Next

The boards of both companies have approved the deal. 

The closing of the acquisition and issuing of Misonix shares hinges on approval by Misonix shareholders — as well as 55 percent of Solys Series E unitholders, a majority of its common unitholders, Series A unitholders, Series B unitholders, Series C unitholders and Series D unitholders.

The transaction is expected to be completed in the third quarter of 2019.

Related Links: 

The Daily Biotech Pulse: Nantkwest Reports Positive Cancer Vaccine Trial Results, Sarepta Offering

The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs

Photo courtesy of Misonix. 

Posted In: Solsys MedicalTheraskinNewsHealth CareM&AGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.